Positive News SentimentPositive NewsNASDAQ:BHST BioHarvest Sciences (BHST) Stock Price, News & Analysis $1.92 -0.08 (-4.00%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$1.90 -0.02 (-1.04%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About BioHarvest Sciences Stock (NASDAQ:BHST) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BioHarvest Sciences alerts:Sign Up Key Stats Today's Range$1.82▼$2.0650-Day Range$1.92▼$3.9652-Week Range$1.82▼$12.80Volume69,615 shsAverage Volume40,984 shsMarket Capitalization$37.67 millionP/E RatioN/ADividend YieldN/APrice Target$10.00Consensus RatingHold Company Overview BioHarvest Sciences Inc. is a biotechnology company that specializes in the development and commercialization of plant-based active ingredients through proprietary cell-culture technology. By growing undifferentiated plant cells in controlled bioreactor environments, the company aims to produce full-spectrum phytonutrients and botanical compounds that are difficult to obtain through traditional farming methods. This approach is designed to deliver consistent, high-purity extracts with reduced environmental impact and supply-chain variability. The company’s product portfolio focuses on applications across the cosmeceutical, nutraceutical and health-and-wellness markets. Utilizing its “living plant cell” methodology, BioHarvest Sciences creates concentrates rich in natural antioxidants, peptides and other bioactive molecules. These ingredients are formulated for skin-care serums, dietary supplements and functional beverages, targeting consumers and manufacturers seeking clean-label and scientifically backed botanical solutions. BioHarvest Sciences has pursued collaborative partnerships with research institutions and commercial enterprises to advance its cell-culture platform and expand market reach. While its technology development is headquartered in North America, the company’s ingredients have attracted interest from cosmetics and food firms in Europe and Asia. As it continues to scale production and refine its bioreactor processes, BioHarvest Sciences positions itself at the intersection of cellular agriculture and plant-derived therapeutics.AI Generated. May Contain Errors. Read More BioHarvest Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks60th Percentile Overall ScoreBHST MarketRank™: BioHarvest Sciences scored higher than 60% of companies evaluated by MarketBeat, and ranked 369th out of 836 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingBioHarvest Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialBioHarvest Sciences has a consensus price target of $10.00, representing about 420.8% upside from its current price of $1.92.Amount of Analyst CoverageBioHarvest Sciences has only been the subject of 1 research reports in the past 90 days.Read more about BioHarvest Sciences' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for BioHarvest Sciences are expected to grow in the coming year, from ($0.45) to ($0.13) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of BioHarvest Sciences is -3.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BioHarvest Sciences is -3.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBioHarvest Sciences has a P/B Ratio of 1.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about BioHarvest Sciences' valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.37% of the float of BioHarvest Sciences has been sold short.Short Interest Ratio / Days to CoverBioHarvest Sciences has a short interest ratio ("days to cover") of 1.93, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in BioHarvest Sciences has recently decreased by 0.06%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBioHarvest Sciences does not currently pay a dividend.Dividend GrowthBioHarvest Sciences does not have a long track record of dividend growth. News and Social Media2.6 / 5News SentimentN/A News SentimentBioHarvest Sciences has a news sentiment score of 1.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.89 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for BioHarvest Sciences this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 1 people have added BioHarvest Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, BioHarvest Sciences insiders have not sold or bought any company stock.Percentage Held by InstitutionsBioHarvest Sciences has minimal institutional ownership at this time.Read more about BioHarvest Sciences' insider trading history. Receive BHST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioHarvest Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BHST Stock News HeadlinesBioHarvest Sciences (NASDAQ:BHST) Shares Down 0.7% - What's Next?July 17, 2026 | americanbankingnews.comBioHarvest Sciences Inc (BHST) Stock Price, Quote, News & HistoryJuly 15, 2026 | benzinga.comThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.July 25 at 1:00 AM | Chaikin Analytics (Ad)BioHarvest lands $1.4M grant for AI-driven plant scienceJuly 15, 2026 | proactiveinvestors.comBioHarvest lands $1.4M grant for AI-driven plant scienceJuly 15, 2026 | proactiveinvestors.comBioHarvest Sciences Stock Short Interest Report | NASDAQ:BHST | BenzingaJune 26, 2026 | benzinga.comBioHarvest Sciences to Showcase Botanical Synthesis at 2026 BIO International ConventionJune 18, 2026 | tipranks.comBioHarvest Sciences and Tate & Lyle expand sweetener development programMay 19, 2026 | proactiveinvestors.comSee More Headlines BHST Stock Analysis - Frequently Asked Questions How have BHST shares performed this year? BioHarvest Sciences' stock was trading at $5.19 at the beginning of 2026. Since then, BHST stock has decreased by 63.0% and is now trading at $1.92. How were BioHarvest Sciences' earnings last quarter? BioHarvest Sciences Inc. (NASDAQ:BHST) announced its quarterly earnings results on Thursday, May, 14th. The company reported ($0.11) earnings per share for the quarter, beating analysts' consensus estimates of ($0.13) by $0.02. The business had revenue of $8.51 million for the quarter, compared to the consensus estimate of $8.50 million. BioHarvest Sciences had a negative trailing twelve-month return on equity of 76.03% and a negative net margin of 32.54%. Read the conference call transcript. How do I buy shares of BioHarvest Sciences? Shares of BHST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/14/2026Today7/25/2026Next Earnings (Estimated)8/10/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:BHST Previous SymbolNASDAQ:BHST CIK1723464 Webbioharvest.com Phone646-863-2177FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Price Target for BioHarvest Sciences$10.00 High Price Target$10.00 Low Price Target$10.00 Potential Upside/Downside+420.8%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$11.14 million Net Margins-32.54% Pretax Margin-32.30% Return on Equity-76.03% Return on Assets-25.30% Debt Debt-to-Equity Ratio0.03 Current Ratio2.96 Quick Ratio2.44 Sales & Book Value Annual Sales$34.51 million Price / Sales1.09 Cash FlowN/A Price / Cash FlowN/A Book Value$1.30 per share Price / Book1.48Miscellaneous Outstanding Shares19,620,000Free FloatN/AMarket Cap$37.67 million OptionableN/A Beta0.87 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:BHST) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredThree oil giants buried the same discovery for 50 yearsIn 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...Behind the Markets | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioHarvest Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioHarvest Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
